Obido, Al-nadjer .
HRN: 27-43-22 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/08/2025
12/15/2025
IV
255mg
Q6
Pcap C
Checking Final Appropriateness